Skip to main content
ZYUS Life Sciences Corporation logo

ZYUS Life Sciences Corporation — Investor Relations & Filings

Ticker · ZYUS ISIN · CA9899601095 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 299 across all filing types
Latest filing 2024-05-27 AGM Information
Country CA Canada
Listing TSXV ZYUS

About ZYUS Life Sciences Corporation

https://www.zyus.com/

ZYUS Life Sciences Corporation is a clinical-stage life sciences company dedicated to the development and commercialization of novel, non-opioid pharmaceutical drug candidates. The company focuses on proprietary cannabinoid-based therapeutics, or phyto-therapeutics, targeting the treatment of chronic and neuropathic pain. ZYUS's vision is to redefine the standard of care in pain management by developing evidence-based alternatives to conventional treatments, including opioids and NSAIDs. The core business involves advancing these drug product candidates through clinical trials, exemplified by the ongoing Phase 2a UTOPIA-1 trial evaluating a novel non-opioid pain drug.

Recent filings

Filing Released Lang Actions
Management information circular - English.pdf
AGM Information Classification · 100% confidence The document is titled as a "Notice of Annual General and Special Meeting of Shareholders" and includes a "Management Information Circular." It details the agenda for the upcoming annual general meeting (AGM) including election of directors, reappointment of auditors, approval of equity compensation plans, and other shareholder matters. It also references proxy solicitation and voting instructions. The document contains detailed proxy and meeting information, typical of materials sent to shareholders before an AGM. It is not the actual annual report or financial statements but rather the notice and circular related to the AGM. Therefore, this document fits the category of AGM Information (AGM-R). The document length and content confirm it is not a brief announcement or a regulatory filing but a full AGM notice and circular.
2024-05-27 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form and notice for the Annual General and Special Meeting of Zyus Life Sciences Corporation scheduled for June 27, 2024. It includes detailed instructions on proxy voting, meeting logistics, and references to meeting materials such as the management information circular, annual financial statements, and management's discussion and analysis. The document is primarily intended to solicit votes from shareholders and provide information about the meeting and voting process. It does not contain the actual annual report, financial statements, or detailed financial data itself but rather directs shareholders to where these materials can be accessed electronically or requested by mail. Therefore, this document is best classified as Proxy Solicitation & Information Statement (PSI).
2024-05-27 English
News release - English.pdf
Investor Presentation Classification · 90% confidence The document is a press release announcing that ZYUS Life Sciences Corporation will present at the Sidoti Virtual Investor Conference on May 8-9, 2024. It includes details about the event, the company, and forward-looking statements. There is no financial data, no detailed report, no voting results, no management changes, no earnings data, and no regulatory filings. The document is an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. Therefore, the most appropriate classification is Investor Presentation (IP) since it relates to a presentation for investors focusing on financials, strategy, and market position, even though the actual presentation is to be held in the future. Confidence is high because the document clearly states it is about an investor conference presentation.
2024-05-08 English
News release - English.pdf
Report Publication Announcement Classification · 95% confidence The document is a press release announcing the completion and filing of the company's annual audited financial statements, management's discussion and analysis, and CEO/CFO certifications for the fiscal year ended December 31, 2023. It states that these documents have been released and filed on SEDAR+, but the actual financial statements and detailed reports are not included in this text. The document is relatively short (4420 characters) and serves as an announcement of the availability of the annual filings rather than the filings themselves. According to the 'Menu vs Meal' rule, such announcements should be classified as Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself. Therefore, the appropriate classification is RPA with high confidence.
2024-05-07 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the financial year ended December 31, 2023. The document is a certification letter and does not contain actual financial data or the full annual report itself. It references the annual filings but is primarily an officer certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K). The document length is short (3141 characters), consistent with a certification letter rather than a full report.
2024-05-07 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the annual filings including the AIF, annual financial statements, and annual MD&A for the financial year ended December 31, 2023. The document is a certification letter and does not contain actual financial data or the full annual report itself. It references the annual filings but is primarily an officer certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or Management Reports (MDA). The document length is short (3113 characters) and it is a certification form, not the full report or announcement of report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2024-05-07 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.